BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37736822)

  • 1. The impact of microscopic extrathyroidal extension on the clinical outcome of classic subtype papillary thyroid microcarcinoma: a multicenter study.
    Zuhur SS; Aggul H; Avci U; Erol S; Tuna MM; Uysal S; Akbaba G; Kilinc F; Catak M; Tekin S; Ozturk BO; Yavuz HC; Kadioglu P; Cinar N; Bayraktaroglu T; Topcu B; Altuntas Y; Elbuken G
    Endocrine; 2024 Mar; 83(3):700-707. PubMed ID: 37736822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Papillary thyroid microcarcinoma with minimal extrathyroidal extension. Is its course so indolent that it requires a less aggressive treatment?
    Ruiz Pardo J; Ríos Zambudio A; Rodríguez González JM; Paredes Quiles M; Soriano Giménez V; Oviedo Ramírez MI; Hernández Martínez AM; Parrilla Paricio P
    Rev Clin Esp (Barc); 2021 Mar; 221(3):131-138. PubMed ID: 33998460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Papillary thyroid microcarcinoma with minimal extrathyroidal extension. Is its course so indolent that it requires a less aggressive treatment?
    Ruiz Pardo J; Ríos Zambudio A; Rodríguez González JM; Paredes Quiles M; Soriano Giménez V; Oviedo Ramírez MI; Hernández Martínez AM; Parrilla Paricio P
    Rev Clin Esp; 2021 Mar; 221(3):131-138. PubMed ID: 32216965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of multifocality in papillary thyroid carcinoma.
    Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
    Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive factors of lateral lymph node metastasis in solitary papillary thyroid microcarcinoma without gross extrathyroidal extension.
    Zhang X; Zhang L; Xue S; Wang P; Chen G
    Asian J Surg; 2019 Apr; 42(4):563-570. PubMed ID: 30078501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors of Metastatic Lymph Nodes in Papillary Thyroid Microcarcinoma.
    Ruiz Pardo J; Ríos A; Rodríguez JM; Paredes M; Soriano V; Oviedo MI; Hernández AM; Parrilla P
    Cir Esp (Engl Ed); 2020 Apr; 98(4):219-225. PubMed ID: 31980154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should central lymph node dissection be considered for all papillary thyroid microcarcinoma?
    Chang YW; Kim HS; Kim HY; Lee JB; Bae JW; Son GS
    Asian J Surg; 2016 Oct; 39(4):197-201. PubMed ID: 25913730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Retrospective comparison of screening criteria for active surveillance for papillary thyroid microcarcinoma].
    Qian K; Sun TQ; Guo K; Zheng XK; Li DS; Wei WW; Wu Y; Ji QH; Wang ZY
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 52(6):430-434. PubMed ID: 28635215
    [No Abstract]   [Full Text] [Related]  

  • 9. Extent of Surgery and the Prognosis of Unilateral Papillary Thyroid Microcarcinoma.
    Zhao H; Cui L
    Front Endocrinol (Lausanne); 2021; 12():655608. PubMed ID: 34220708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of cN0 papillary thyroid microcarcinoma patients according to risk-scoring model for central lymph node metastasis and predictors of recurrence.
    Feng JW; Ye J; Wu WX; Qu Z; Qin AC; Jiang Y
    J Endocrinol Invest; 2020 Dec; 43(12):1807-1817. PubMed ID: 32557354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Papillary thyroid microcarcinoma: extrathyroidal extension, lymph node metastases, and risk factors for recurrence in a high prevalence of goiter area.
    Lombardi CP; Bellantone R; De Crea C; Paladino NC; Fadda G; Salvatori M; Raffaelli M
    World J Surg; 2010 Jun; 34(6):1214-21. PubMed ID: 20052467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral location and infiltrative margin predict invasive features of papillary thyroid microcarcinoma.
    Lee WK; Lee J; Kim H; Lee SG; Choi SH; Jeong S; Kwon HJ; Jung SG; Jo YS
    Eur J Endocrinol; 2019 Aug; 181(2):139-149. PubMed ID: 31146263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Margin Positivity and Survival in Papillary Thyroid Microcarcinoma: A National Cancer Database Analysis.
    Lee CI; Kutlu O; Khan ZF; Picado O; Lew JI
    J Am Coll Surg; 2021 Oct; 233(4):537-544. PubMed ID: 34265429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lateral lymph node metastasis in papillary thyroid microcarcinoma: a study of 5241 follow-up patients.
    Ruan J; Chen Z; Chen S; Xu Z; Wen L; Mao Z; Shen J; Liu J; Wang W
    Endocrine; 2024 Feb; 83(2):414-421. PubMed ID: 37596455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for neck nodal metastasis in papillary thyroid microcarcinoma: a study of 1066 patients.
    Zhang L; Wei WJ; Ji QH; Zhu YX; Wang ZY; Wang Y; Huang CP; Shen Q; Li DS; Wu Y
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1250-7. PubMed ID: 22319042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of Low-Risk Papillary Thyroid Microcarcinoma During Active Surveillance: Interim Analysis of a Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma in Korea.
    Lee EK; Moon JH; Hwangbo Y; Ryu CH; Cho SW; Choi JY; Chung EJ; Jeong WJ; Jung YS; Ryu J; Kim SJ; Kim MJ; Kim YK; Lee CY; Lee JY; Yu HW; Hah JH; Lee KE; Lee YJ; Park SK; Park DJ; Kim JH; Park YJ
    Thyroid; 2022 Nov; 32(11):1328-1336. PubMed ID: 36205563
    [No Abstract]   [Full Text] [Related]  

  • 17. Do Histologically Aggressive Subtypes of Papillary Thyroid Microcarcinoma have Worse Clinical Outcome than Non-Aggressive Papillary Thyroid Microcarcinoma Subtypes? A Multicenter Cohort Study.
    Zuhur SS; Aggul H; Avci U; Erol S; Tuna MM; Uysal S; Akbaba G; Kilinç F; Catak M; Tekin S; Bilen OI; Öztürk BO; Erden EB; Elbuken G; Yavuz HC; Kadioglu P; Cinar N; Kutluturk F; Bayraktaroglu T; Topçu B; Arslan AI; Gucer H; Cihangiroglu G; Topal CS; Ozturk T; Tekin L; Artas G; Akcay E; Gun BD; Altuntas Y
    Horm Metab Res; 2023 May; 55(5):323-332. PubMed ID: 36764327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimal Extrathyroidal Extension in Predicting 1-Year Outcomes: A Longitudinal Multicenter Study of Low-to-Intermediate-Risk Papillary Thyroid Carcinoma (ITCO#4).
    Forleo R; Grani G; Alfò M; Zilioli V; Giubbini R; Zatelli MC; Gagliardi I; Piovesan A; Ragni A; Morelli S; Puxeddu E; Pagano L; Deandrea M; Ceresini G; Torlontano M; Puligheddu B; Antonelli A; Centanni M; Fugazzola L; Spiazzi G; Monti S; Rossetto R; Monzani F; Tallini G; Crescenzi A; Sparano C; Bruno R; Repaci A; Tumino D; Pezzullo L; Lombardi CP; Ferraro Petrillo U; Filetti S; Durante C; Castagna MG
    Thyroid; 2021 Dec; 31(12):1814-1821. PubMed ID: 34541894
    [No Abstract]   [Full Text] [Related]  

  • 19. Minimal extrathyroidal extension is associated with lymph node metastasis in single papillary thyroid microcarcinoma: a retrospective analysis of 814 patients.
    Song RY; Kim HS; Kang KH
    World J Surg Oncol; 2022 May; 20(1):170. PubMed ID: 35643530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical predictors of lymph node metastasis and survival rate in papillary thyroid microcarcinoma: analysis of 3607 patients at a single institution.
    Xu Y; Xu L; Wang J
    J Surg Res; 2018 Jan; 221():128-134. PubMed ID: 29229118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.